[Featured Stock] "Unispace FDA Approval in the US" Innosis Up Over 7%

Featured Stock
Featured Stock.

The stock price of Innosis, an orthopedic implant company, is rising following the news of the U.S. Food and Drug Administration (FDA) approval of its cervical cage product, 'Unispace.' As of 10:43 AM on the 17th, Innosis is trading at 1,644 KRW, up 117 KRW (7.66%) compared to the previous trading day.

On the same day, Innosis announced, "Unispace has obtained premarket approval (510k) from the FDA" on the 17th. The 510k is a system through which the FDA verifies the safety and effectiveness of medical devices.

Unispace is an integrated device combining a cage that replaces damaged discs and fixation screws, which is expected to shorten surgery time and enable faster recovery. Innosis plans to actively expand its portfolio in the U.S. medical device market through this FDA approval.

This content was produced with the assistance of AI translation services.